Header Logo

Connection

Gary Chmielewski to Neoplasm Staging

This is a "connection" page, showing publications Gary Chmielewski has written about Neoplasm Staging.
Connection Strength

0.171
  1. Positron-emission tomography as a prognostic tool for early-stage lung cancer. Am J Surg. 2006 Mar; 191(3):433-6.
    View in: PubMed
    Score: 0.057
  2. Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
    View in: PubMed
    Score: 0.035
  3. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
    View in: PubMed
    Score: 0.026
  4. Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
    View in: PubMed
    Score: 0.022
  5. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):928-35.
    View in: PubMed
    Score: 0.019
  6. Lysyl oxidase expression in bronchogenic carcinoma. Am J Surg. 2005 Mar; 189(3):297-301.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.